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ABSTRACT
Phthiocerol dimycocerosates (PDIM) are a group of cell surface-associated apolar lipids ofMycobacterium tuberculosis and
closely related mycobacteria, such asMycobacterium bovis andMycobacterium leprae. A characteristic methoxy group of these
lipids is generated from the methylation of a hydroxyl group of the direct precursors, the phthiotriols. The precursors arise from
the reduction of phthiodiolones, the keto intermediates, by a ketoreductase. The putative phthiodiolone ketoreductase (PKR) is
encoded by Rv2951c inM. tuberculosis and BCG_2972c inM. bovis BCG, and these open reading frames (ORFs) encode identical
amino acid sequences. We investigated the cofactor requirement of the BCG_2972c protein. A comparative analysis based on the
crystallographic structures of similar enzymes identified structural elements for binding of coenzyme F420 and hydrophobic ph-
thiodiolones in PKR. Coenzyme F420 is a deazaflavin coenzyme that serves several key functions in pathogenic and nonpatho-
genic mycobacteria. We found that anM. bovis BCGmutant lacking F420-dependent glucose-6-phosphate dehydrogenase (Fgd),
which generates F420H2 (glucose-6-phosphate F420¡ 6-phosphogluconate F420H2), was devoid of phthiocerols and accumu-
lated phthiodiolones. When the mutant was provided with F420H2, a broken-cell slurry of the mutant converted accumulated
phthiodiolones to phthiocerols; F420H2 was generated in situ from F420 and glucose-6-phosphate by the action of Fgd. Thus, the
reactionmixture was competent in reducing phthiodiolones to phthiotriols (phthiodiolones F420H2¡ phthiotriols F420),
which were thenmethylated to phthiocerols. These results established the mycobacterial phthiodiolone ketoreductase as an
F420H2-dependent enzyme (fPKR). A phylogenetic analysis of close homologs of fPKR revealed potential F420-dependent lipid-
modifying enzymes in a broad range of mycobacteria.
IMPORTANCE
Mycobacterium tuberculosis is the causative agent of tuberculosis, and phthiocerol dimycocerosates (PDIM) protect this patho-
gen from the early innate immune response of an infected host. Thus, the PDIM synthesis system is a potential target for the de-
velopment of effective treatments for tuberculosis. The current study shows that a PDIM synthesis enzyme is dependent on the
coenzyme F420. F420 is universally present in mycobacteria and absent in humans. This finding expands the number of experi-
mentally validated F420-dependent enzymes inM. tuberculosis to six, each of which helps the pathogen to evade killing by the
host immune system, and one of which activates an antituberculosis drug, PA-824. This work also has relevance to leprosy, since
similar waxy lipids are found inMycobacterium leprae.
Diacylated polyketides (DPs), a family of waxy compounds, arefound in the cell walls of a group of mostly pathogenic and
slow-growing mycobacteria (Fig. 1) (1, 2). The pathways for the
biosynthesis of DPs are of great interest because these compounds
are virulence factors for Mycobacterium tuberculosis and Mycobac-
terium leprae, which cause tuberculosis (TB) and leprosy, respec-
tively (3–11). It was recently shown that these polyketide deriva-
tives protect M. tuberculosis from the early innate immune
response of an infected host (12). The DPs are generated by
esterifying -glycol-containing long-chain polyketides (PK)
with long-chain multimethyl-branched fatty acids (Fig. 1) (1,
2). In M. tuberculosis, these compounds have two structural
types: phthiocerol dimycocerosates (PDIM or DIM A) and gly-
cosylated phenolphthiocerol dimycocerosates or phenolic gly-
colipids (PGL-tb) (13) (Fig. 1); if the PK units carry a keto
group in place of a methoxy group, the respective variations are
called phthiodiolone dimycocerosates (DIM B) and glycosy-
lated phenolphthiodiolone dimycocerosates (Fig. 1) (13–15).
The above-mentioned methoxy group is generated in two
steps, i.e., reduction of the corresponding keto group to a hy-
droxy group by a phthiodiolone reductase, generating phthio-
triol intermediates, followed by methylation of the hydroxy
group by a methyltransferase (14, 15).
In Mycobacterium tuberculosis, the open reading frames
(ORFs) Rv2951c and Rv2952 encode the phthiodiolone ketore-
ductase (PKR) and phthiotriol methyltransferase, respectively
(13–15). Disruption of Rv2951c eliminates the production of
DIM A and PGL-tb and causes the accumulation of DIM B and
glycosylated phenolphthiodiolone dimycocerosates (13). It has
been indicated that Rv2951c encodes a domain characteristic of
coenzyme F420-dependent N
5,N10-methylene tetrahydrometha-
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nopterin reductase (Mer), but its specific cofactor requirement
has not been determined (14). Mer is a key enzyme in methane
biosynthesis in methanogenic archaea (16), and a well-character-
ized mycobacterial Mer homolog is F420-dependent glucose-6-
phosphate (G6P) dehydrogenase (Fgd) (17–19); all mycobacteria
carry the fgd gene (19, 20).
Coenzyme F420, a deazaflavin derivative, is a major coenzyme
of the methanogenic archaea and of methanogens (16). In the
bacterial domain, it is mostly found in some of the actinobacterial
species, including all mycobacteria and streptomyces, and genome
analysis suggests that F420 is sporadically present in proteobacteria
as well (20–23). At the ground state, the most commonly encoun-
tered form of this coenzyme in biological systems, the midpoint
redox potential value (E0=) of F420 is 360 mV, and it performs
hydride transfer (16, 24). The E0= value of NAD(P), a major
biological hydride transfer coenzyme, is 320 mV (16, 24).
Whether the actinobacteria benefit from the higher reducing
power (lower E0= value) of F420 remains to be determined.
In this report, we describe results from our genetic and chem-
ical analyses and an in vitro enzymatic conversion experiment
which show that PKR is indeed an F420-dependent enzyme, and
accordingly, we have termed it fPKR.
MATERIALS AND METHODS
Growthmediumand culture conditions forMycobacteriumbovisBCG.
M. bovis BCG strain Pasteur 1173P2 (wild type) and a respective mutant
strain lacking functional fgd (ORF BCG_0446) (25, 26) were used in this
study. The mutant strain was obtained during a previous Tn5367 mu-
tagenesis-based study, and it is known to lack the respective enzymatic
activity (26). To clearly map the Tn5367 insertion site in the M. bovis BCG
fgd::Tn5367 strain, a region of the mutant chromosome containing the
interrupted fgd gene, respective upstream and downstream regions, and
the inserted transposon was amplified by use of primers BCGFgd/1F (5=
GGATCCGTCGCCGGGATAGCCGGCGTC3=) and BCGFgd/2R (5=
CTGCAGGTCCCGCTCCGCAGAGAGCCG3=), and the amplicon was
sequenced. The data showed that the transposon was inserted at the
421-bp position of the fgd coding sequence.
Both the wild-type and fgd::Tn5367 strains were grown in Middle-
brook 7H9 liquid medium supplemented with 5% Middlebrook ADC,
0.2% glycerol, and 0.05% Tween 80 (27); the fgd::Tn5367 strain was cul-
tivated in the presence of kanamycin (20 g/ml). The cultures were incu-
bated at 37°C with occasional manual shaking for 2 to 3 weeks. The cells
were recovered by centrifugation at 18,000 g for 15 min at 4°C, washed
with 20 mM potassium phosphate buffer, pH 7.0, and stored at 20°C
until further use.
Heterologous expression and purification of F420-dependent glu-
cose-6-phosphate dehydrogenase. The coding sequence of Mycobacte-
rium smegmatis fgd (msmeg_0777) (19) was PCR amplified and cloned
into the NdeI and BamHI sites of pTEV5, a T7 promoter-based protein
expression vector (28), providing pTEV5-msmeg_0777. The plasmid
was designed to generate recombinant Fgd with an NH2-terminal
His6 tag (MSYYHHHHHHDYDIPTSENLYFQGASH). Escherichia coli
BL21(DE3)(pTEV5-msmeg_0777) was cultivated at 37°C in LB medium
containing 100 g/ml ampicillin. Fgd expression was induced by supple-
menting the culture with isopropyl--D-thiogalactopyranoside (IPTG) to
a final concentration of 0.4 mM. Fgd carrying the His6 tag was purified as
a soluble protein via Ni2-nitrilotriacetic acid chromatography (29, 30);
the enzyme was eluted with 150 mM imidazole, and based on the results of
SDS-PAGE analysis, the preparation was judged to be apparently homo-
geneous. Freshly prepared enzyme was used in the in vitro conversion
experiment.
In vitro conversion of phthiodiolones to phthiotriols. A broken-cell
slurry of M. bovis BCG fgd::Tn5367 was prepared as described previously
(26). In brief, about 0.2 g of wet cells was resuspended in 0.2 ml 20 mM
potassium phosphate buffer, pH 7, and the cells in this suspension were
lysed by use of a mini-bead beater (BioSpec Products, Inc., Bartlesville,
OK) operating at 4,800 rpm; three 1-min bead beatings with intermediate
2-min incubations on ice were used. The cell slurry (0.25 ml) was mixed
with the following at the indicated final concentrations in a total volume
of 0.5 ml: purified recombinant Fgd (20 g), F420 (50 M), and glucose-
6-phosphate (5 mM). The mixture was incubated overnight at 37°C with
gentle shaking. The apolar lipids were isolated from the mixture and an-
alyzed via thin-layer chromatography (TLC) as described below.
Lipid analysis. A cell pellet (about 1 g) of M. bovis BCG or its fgd::
Tn5367 derivative was mixed with 20 ml of a mixture of chloroform-
methanol (2:1 [vol/vol]) and shaken at room temperature (25°C) over-
night. The mixture was filtered using a Whatman grade 1 filter paper (GE
Healthcare Bio-Sciences, Pittsburgh, PA), and then a 0.3% aqueous NaCl
solution (1/5 of the filtrate volume) was added to the resulting filtrate to
generate a chloroform layer that contained the apolar lipids, including
DIM A and DIM B. The chloroform layer was collected and dried under
an N2 stream, and the residue was dissolved in a minimal volume of a
FIG 1 Conversion of phthiodiolone dimycocerosates (DIM B) to phthiocerol dimycocerosates (DIM A) in mycobacteria. The conversion proceeds via
intermediate formation of phthiotriol dimycocerosates by an F420H2-dependent phthiodiolone ketoreductase (fPKR) that is encoded by Rv2951c in Mycobac-
terium tuberculosis (Mtb) and by BCG_2972c in Mycobacterium bovis BCG. The structures of the three classes of dimycocerosates are shown.
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chloroform-methanol mixture (2:1 [vol/vol]). This product was analyzed
via TLC on an aluminum-backed silica gel plate (Merck 5735, silica gel
60F254; Merck KGaA, Darmstadt, Germany), using a mixture of petro-
leum ether and diethyl ether (9:1) as the development solvent (15). The
lipid spots of resolved lipids were visualized by spraying with a 5% mo-
lybdophosphoric acid solution in ethanol followed by charring at 110°C
for 15 min (15); this procedure detects DIM A and DIM B but not the
respective phenolic glycolipids (Fig. 1).
Mass spectrometric analysis of DIM A and DIM B. The lipids to be
analyzed were purified via TLC as follows. To generate an adequate
amount of material, the TLC analysis as shown in each lane of Fig. 3 was
scaled to a multilane format, and a terminal lane was cut off and processed
for the detection of DIM A and/or DIM B bands as described above. Using
a relevant band in the terminal lane as a guide, the silica layers of the
desired dimycocerosate spots were scraped from the rest of the lanes.
From the recovered silica particles, dimycocerosates were extracted with
chloroform-methanol (2:1) and analyzed via matrix-assisted laser desorp-
tion ionization–time of flight (MALDI-TOF) mass spectrometry at the
School of Chemical Sciences Mass Spectrometry Laboratory at the Uni-
versity of Illinois at Urbana-Champaign. Bruker peptide calibration mix-
ture II (angiotensin II, angiotensin I, substance P, bombesin, ACTH clip
1–17, ACTH clip 18 –39, somatostatin 28, bradykinin fragment 1–7, and
porcine renin substrate tetradecapeptide; covered mass range, 700 to
3,200 Da) was used for calibration, and the matrix was 2,5-dihydroxyben-
zoic acid. A Bruker UltrafleXtreme mass spectrometer (Bruker, Bremen,
Germany) equipped with a Smart Beam II laser was used in the positive
mode to acquire MALDI-TOF mass spectra. Samples were analyzed in the
reflectron mode.
Bioinformatic analysis. Homologs of the Rv2951c protein were iden-
tified via a BLASTP search (31) of the NCBI’s nonredundant protein
database, using the amino acid sequence of this protein as the query and
with a specific focus on Mycobacterium species (taxid 1763). Proteins
showing50% identity to the Rv2951c protein were selected for a phylo-
genetic analysis, which was performed as described previously (32). In
brief, the amino acid sequences were aligned and trimmed by use of the
Muscle (33) and Gblocks (34) programs, respectively. A phylogenetic tree
was then constructed using a maximum likelihood-based phylogenetic
reconstruction program, proml, in the Phylip 3.67 package (32), with 100
replicates, and the tree was viewed with FigTree v1.4.2 (http://tree.bio.ed
.ac.uk/software/figtree/).
For identification of the conserved Mer-type secondary structure fea-
tures and F420-binding residues and for prediction of the DIM B-interact-
ing elements in the Rv2951c protein, the amino acid sequences of this
protein and selected Mer homologs for which X-ray crystallographic
three-dimensional structures of the F420-bound forms are available (17,
35–37) were aligned by PROMALS3D at http://prodata.swmed.edu
/promals3d/promals3d.php and by manual adjustments (38).
RESULTS AND DISCUSSION
Analysis of the structural characteristics of theRv2951cprotein.
The goal of this analysis was to determine whether the Rv2951c
protein has the potential to interact with coenzyme F420 and hy-
drophobic substrates, such as phthiodiolones. For this purpose,
we performed a structure-based sequence alignment (Fig. 2) by
utilizing the X-ray crystallographic structures of Mer from two
methanogenic archaea, Methanopyrus kandleri and Methanosar-
cina barkeri (MkMer and MbMer, respectively) (36, 37), and two
Mer homologs, an F420-dependent secondary alcohol dehydroge-
nase (Adf) from another methanogen (35) and Fgd of M. tubercu-
losis (17) (Fig. 2). For Fgd, Adf, and MbMer, structures of F420-
bound forms were used. The primary structure of the recently
described F420-dependent hydroxymycolic acid dehydrogenase of
M. tuberculosis (fHMAD or Rv0132c) (39) was also included in the
analysis (Fig. 2). The alignment showed that the predicted second-
ary structural features of the Rv2951c protein are highly similar to
those found in Fgd, Adf, and MbMer and that the protein carries
the features that allow a Mer homolog to bind F420 (Fig. 2). Mer,
Adf, and Fgd induce a butterfly conformation at the si face of
bound F420 by holding the coenzyme with conserved structural
elements (marked with asterisks in Fig. 2) (17, 35–37). In Adf,
His39 and Glu108 hold the pyrimidine ring of F420, and the hy-
droxybenzyl wing of the coenzyme is fixed by Val193 and Ile227
(35). These interactions are conserved in Fgd and Mer, the equiv-
alent residues in fHMAD are His78 and Glu147, and those in the
Rv2951c protein are His43 and Glu129 (Fig. 2). In Adf, Fgd, and
Mer, the central pyridine ring of F420 is placed outside the plane of
the two flanking rings via an unusual structural element, a bulge,
that contains a nonprolyl cis-peptide bond (17, 35–37). Among
Mer homologs, this element was first identified in MkMer, where
Gly64 and Ile65 form the unusual cis-peptide bond (37) (Fig. 2). In
Fgd, this bond occurs between Ser73 and Val74, and the carbonyl
oxygen of Ser73 and the side chain of Val74 interact with the re face
of the central pyridine ring (17). The respective residues in other
enzymes are as follows (Fig. 2): Cys72 and Ile73 in Adf, Gly61 and
Val62 in MbMer, Gly64 and Ile65 in MkMer, Gly121 and Val122 in
fHMAD, and Cys94 and Val95 in the Rv2951c protein. The replace-
ment of Ser73 as in Fgd with Cys or Gly in other Mer homologs is
considered conservative, as these three amino acids are highly
compatible in terms of their hydrophobicities, isoelectric points,
and volumes (39–43). In Adf, the formation of the unfavorable
nonprolyl cis-peptide bond is dictated by a highly conserved Asp
residue (Asp38) (Fig. 2), and the position of the carboxylate of this
residue is fixed by a salt bridge with an Arg residue (Arg79) (35).
Both Asp38 and Arg79 of Adf are conserved in Fgd, MkMer,
MbMer, fHMAD, and the Rv2951c protein (Fig. 2), and the pre-
viously reported consensus sequence for the bulge [D/E-H-X(20 –
30)-I/L-S/G-X-I/V/A-X5-R/H] (35) fits the Rv2951c protein. Thus,
the Rv2951c protein carries all sequence features for binding co-
enzyme F420.
In Adf, the hydroxybenzyl unit of F420 interacts with Val
193 and
Leu227, which are hydrophobic, and this selection is justified by
the localization of the hydrocarbon chain of the secondary alcohol
in this region (35). Similarly, for MkMer, the equivalent region
carries Ala197 and Tyr229, which are proposed to interact with the
pterin ring of tetrahydromethanopterin (37). A partial conserva-
tion is seen in fHMAD (Ala232 and Glu263), which also oxidizes
hydrophobic substrates, i.e., hydroxymycolic acids (39). In con-
trast, the homologous residues in Fgd are Ser196 and Glu230, the
latter of which is followed by Lys232, and these elements not only
accommodate the hydroxybenzyl ring but also will be near the
charged glucose-6-phosphate (17). Based on these observations,
the presence of Val215 and Val248 at the equivalent positions and an
absence of the conservation of Lys232 of Fgd in the Rv2951c pro-
tein are consistent with the possibility that the Rv2951c protein
acts on DIM B, a rather hydrophobic substrate. Hence, the
Rv2951c protein has the structural elements for binding both F420
and the hydrophobic phthiodiolone moiety of DIM B and glyco-
sylated phenolphthiodiolone dimycocerosates. These observa-
tions support the hypothesis that the Rv2951c protein utilizes
F420H2 as the electron source for the reduction of phthiodiolone.
Genetic analysis of the requirement for F420H2 in phthiodi-
olone reduction. Our strategy for testing the above-mentioned
hypothesis was based on the following observations. Several stud-
ies have shown that, at least under laboratory growth conditions
Purwantini et al.
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where glycerol or glucose is used as the carbon and energy source,
Fgd is the major F420H2-generating enzyme in the mycobacteria,
and elimination or disruption of the fgd gene blocks F420H2-de-
pendent reactions. For example, the M. smegmatis	fgd strain can-
not carry out reduction of NO2, which requires F420H2 (44). Sim-
ilarly, in M. tuberculosis and M. bovis BCG, inactivation of the fgd
gene makes these organisms resistant to PA-824 (45); PA-824 as
such is not an antimycobacterial agent, but its reaction with
F420H2 as catalyzed by a deazaflavin-dependent nitroreductase
(Ddn) releases NO that helps to kill mycobacteria (46, 47). Also,
inactivation of the fgd gene eliminates aflatoxin degradation capa-
bility in M. smegmatis, as this process requires the actions of two
families of F420H2-dependent reductases (48). A study with a mu-
tant lacking Fgd activity helped to establish the role of F420H2 in
the defense against oxidative stress in mycobacteria (49). Accord-
ingly, we rationalized that if the Rv2951c protein uses F420H2 as
the electron source for reducing phthiodiolone, an M. tuberculosis
strain lacking functional fgd will produce DIM B and glycosylated
phenolphthiodiolone dimycocerosates but not the respective ph-
thiotriol forms, and therefore will lack DIM A and PGL-tb (Fig. 1).
We tested the above-mentioned hypothesis in the Mycobacte-
rium bovis BCG model by using genetic analysis. The DIM A and
DIM B profiles of this organism and M. tuberculosis are the same
(14, 15, 50, 51). The homolog of the Rv2951c protein of M. tuber-
culosis in M. bovis BCG is the BCG_2972c protein, and these pro-
teins have identical amino acid sequences (25). M. bovis BCG pro-
duces DIM A and DIM B (Fig. 3, wt lane) and therefore is capable
of reducing DIM B to phthiotriol dimycocerosates. Since a focus
on either DIM B or glycosylated phenolphthiodiolone dimycoc-
erosates is sufficient to identify the electron source utilized in the
reduction of the keto group of the phthiodiolone moiety, we lim-
ited the scope of our work to only the conversion of DIM B to DIM
A (the nonglycosylated forms) in M. bovis BCG (52). We exam-
ined the DIM A and DIM B contents of wild-type M. bovis BCG
strain Pasteur 1173P2 and a respective mutant strain (fgd::
Tn5367) lacking functional fgd (BCG_0446 ORF) (25) via TLC
FIG 2 Putative F420-binding residues in F420-dependent phthiodiolone ketoreductase (fPKR). The figure presents a structure-guided multiple-sequence align-
ment generated at the PROMALS3D Web server (38). The ORFs encoding fPKR in Mycobacterium tuberculosis H37Rv (Rv2951c; http://www.ncbi.nlm.nih.gov
/protein/CCP45755.1) and Mycobacterium bovis BCG strain Pasteur 1173P2 (BCG_2972c; http://www.ncbi.nlm.nih.gov/protein/CAL72961.1) have identical
sequences. The sequences aligned (full name, abbreviation, PDB ID wherever applicable) are as follows: F420-dependent secondary alcohol dehydrogenase from
Methanoculleus thermophilicus, Adf, 1rhc (35); F420-dependent glucose-6-phosphate dehydrogenase of M. tuberculosis, Fgd, 3b4y (17); F420-dependent methyl-
enetetrahydromethanopterin reductase of Methanosarcina barkeri, MbMer, 1z69 (36, 37); F420-dependent methylenetetrahydromethanopterin reductase of
Methanopyrus kandleri, MkMer, 1ezw (36, 37); F420-dependent hydroxymycolic acid dehydrogenase of M. tuberculosis, fHMAD (http://www.ncbi.nlm.nih.gov
/protein/P96809.1) (39); and F420-dependent phthiodiolone ketoreductase, Rv2951c/BCG_2972c (this report). Yellow-shaded, underlined residues, experimen-
tally determined F420-binding residues (17, 35, 36); yellow-shaded residues, predicted F420-binding residues; amino acid residues in red and blue letters, known
(Adf, Fgd, MbMer, and MkMer) and predicted (fHMAD and fPKR) locations of alpha helices and beta sheets, respectively; CSS, consensus secondary structure
(red h’s and blue e’s represent alpha helices and beta sheets, respectively); *, residues responsible for inducing a butterfly conformation at the si face of bound F420
(17, 35–37).
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analysis. The resulting profile for M. bovis BCG fgd::Tn5367 (Fig.
3, 	fgd lane), which lacked F420H2 (the reductant), was similar to
that observed previously with an M. tuberculosis H37Rv derivative
lacking the Rv2951c protein (the reductase enzyme) (13). To val-
idate the TLC data, we performed MALDI mass spectrometric
analysis with the materials recovered from the specific bands. The
DIM A and DIM B preparations obtained from the wild-type
strain (Fig. 3, wt lane) yielded characteristic spectra (Fig. 4) (13,
53). The observed [DIM A  Na] ion, with an m/z value of
1,348.738 (Fig. 4, left panel), represents a molecule with 89 carbon
atoms (C89 species; theoretical mass, 1,348.3409) that has been
reported for the highest-intensity peak in the mass spectrum for a
DIM A preparation from M. bovis BCG strain Tokyo 172 (13, 54).
The m/z values for other ions were higher or lower than that for
the C89 species, by n 14 units (Fig. 4, left panel), and this result
is consistent with n representing larger or smaller numbers of
methylene (CH2) groups present in the respective molecules. Sim-
ilarly, the DIM B preparation produced an ion with an m/z value
of 1,332.541 (Fig. 4, right panel), which is 16 mass units lower than
that of the above-mentioned [DIM ANa] ion, with 89 carbon
atoms (Fig. 4, left panel). This difference represents the conver-
sion of a carbonyl group (C
O, as in DIM B) to a methoxy group
(CH-OCH3, as in DIM A). Several other peaks in the DIM B spec-
trum had cognate peaks in the DIM A spectrum (Fig. 4). A mass
spectrometric analysis of DIM B isolated from the fgd::Tn5367
strain (Fig. 3, 	fgd lane) produced the same results (data not
shown). These findings clearly establish that M. bovis BCG fgd::
Tn5367 lacks DIM A and accumulates DIM B. Since M. bovis BCG
fgd::Tn5367 carries a homolog of the Rv2951c protein or phthio-
diolone ketoreductase (the BCG_2972c protein), the inability to
convert DIM B to DIM A was due to the unavailability of F420H2,
which prevented the generation of the phthiotriol intermediate,
the methylation substrate (Fig. 1) (14, 15). An obvious explana-
tion for this observation is that the BCG_2972c protein (a ho-
molog of the Rv2951c protein of M. tuberculosis) is an F420H2-
dependent phthiodiolone ketoreductase (fPKR).
Phthiodiolone ketoreductase reaction. The phthiodiolone
ketoreductase reaction is as follows: phthiodiolone  F420H2¡
FIG 3 Analysis of dimycocerosates extracted from Mycobacterium bovis BCG
strains and an in vitro conversion system via thin-layer chromatography
(TLC). Lanes: wt, M. bovis BCG strain Pasteur 1173P2; 	fgd, M. bovis BCG
fgd::Tn5367;	fgd F420H2, an in vitro reaction mixture containing a broken-
cell suspension of M. bovis BCG fgd::Tn5367 (source of DIM B and fPKR) and
F420H2 generated in situ from F420 and glucose-6-phosphate by the action of a
purified recombinant form of Fgd of Mycobacterium smegmatis. The details of
the in vitro reaction, extraction of apolar lipids from mycobacterial cells and
the in vitro reaction mixture, and TLC analysis of apolar lipids appear in Ma-
terials and Methods. The TLC analysis detected DIM A and DIM B but not the
respective phenolic glycolipids. DIM A and DIM B bands are marked; the
identities of U1 and U2 are unknown.
FIG 4 MALDI-TOF mass spectra of phthiodiolone dimycocerosates (DIM B) and phthiocerol dimycocerosates (DIM A) recovered from wild-type Mycobac-
terium bovis BCG (strain Pasteur 1173P2). The products analyzed correspond to the wt lane in Fig. 3. The peaks for [MNa] species with exclusively the 12C
isotope that are characteristic of DIM A and DIM B of M. bovis BCG (13) are labeled with their respective numbers of carbon atoms and observed m/z values. For
each ion, the respective theoretical mass value (72) is shown within parentheses. The observed m/z values deviated from the theoretical mass values by 0.34 to 0.64
unit for [DIM ANa] ions and by 0.19 to 0.24 unit for [DIM BNa] ions. Such deviations have been observed by mass spectrometry analysis of DIM A and
DIM B of Mycobacterium bovis BCG (54).
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phthiotriol F420. Alternatively, F420H2 may serve as an indirect
source of reductant for phthiodiolone reduction. Resolution of
these possibilities would require demonstration of enzymatic
and/or F420-binding activity of the homogeneous enzyme.
Demonstration of F420H2-dependent phthiodiolone ketore-
ductase activity in cell extracts. We validated the conclusion de-
rived from genetic analysis at the enzymatic activity level. In this
experiment, a broken-cell slurry of M. bovis BCG fgd::Tn5367 was
used as the source of phthiodiolone dimycocerosate (DIM B) and
phthiodiolone reductase (the BCG_2972c protein), and the
needed F420H2 was generated in situ from added F420, glucose-6-
phosphate, and purified Fgd via the following reaction: glucose-
6-phosphate  F420 ¡ F420H2  6-phosphogluconate. A TLC
analysis showed that upon incubation at 37°C, the system con-
verted DIM B present in M. bovis BCG fgd::Tn5367 to a DIM
A-like product and two other compounds that were assigned the
trivial names U1 and U2 (Fig. 3,	fgd F420H2 lane). The putative
DIM A product isolated from the in vitro reaction mixture was
analyzed via MALDI mass spectrometry, and in the resulting spec-
trum the following peaks had m/z values (numbers of carbon at-
oms) characteristic of DIM A: 1,348.354 (C89), 1,362.179 (C90),
1,376.245 (C91), 1,390.249 (C92), 1,404.360 (C93), 1,418.424 (C94),
1,432.277 (C95), and 1,446.239 (C96). The other reaction products,
U1 and U2 (Fig. 3, 	fgd  F420H2 lane), remain to be identified,
but the former seemed to exist in wild-type M. bovis BCG (Fig. 3,
wt lane). These results showed that the in vitro reaction that was
catalyzed by the enzyme systems from the mutant strain (fgd::
Tn5367) and utilized F420H2 generated by purified Fgd as a reduc-
tant converted DIM B to DIM A. This conversion must have oc-
curred in two steps: F420H2-dependent reduction of DIM B to the
respective phthiotriol derivatives, catalyzed by the BCG_2972c
protein; and methylation of phthiotriols to phthiocerols (DIM A)
by a methyltransferase, the BCG_2973 protein. It remains to be
investigated whether the production of U1 or U2 was caused by
Fgd, F420H2, glucose-6-phosphate, 6-phosphogluconate, fPKR, or
other enzymes of M. bovis BCG.
Phylogenetic analysis of mycobacterial homologs of the
Rv2951c protein (fPKR), revealing potentially new F420-depen-
dent lipid-modifying enzymes in mycobacteria. The homologs
of the full-length Rv2951c protein identified in the BLASTP search
fell into two distinct groups in terms of amino acid sequence iden-
tity with the Rv2951c protein: those with 50% and those with
40% identity. This selection was justified by the absence of ho-
mologs in the intermediate range and therefore provided a sharp
boundary. The40% group included F420-dependent glucose-6-
phosphate dehydrogenase (Fgd) (18, 19), F420-dependent hy-
droxymycolic acid dehydrogenase (fHMAD) (39), and putative
flavin-containing enzymes. On the other hand, the 50% group
was comprised of phthiodiolone ketoreductases and proteins of
unknown function, and due to this closer relationship with the
Rv2951c protein, we performed a maximum likelihood-based
phylogenetic analysis with select representatives of this group (Fig.
5); the full-length sequence of every homolog, with appropriate
trimming as described in Materials and Methods, was used in the
analysis. The analysis revealed major clades, each of which had two
or more subgroups (Fig. 5). Clade Ia represented the closest ho-
mologs of fPKR (with83% amino acid sequence identities with
the Rv2951c protein). These proteins belonged to a group of slow-
growing mycobacteria which are known to contain PDIM (55)
and to carry PapA5, which catalyzes a committed step of PDIM
synthesis in M. tuberculosis (56). PapA5, a polyketide-associated
protein, is an acyltransferase, and the respective gene is part of a
PDIM synthesis gene cluster (7–9, 14, 50, 57–59). Accordingly,
clade Ia homologs of the Rv2951c protein are likely to be bona fide
fPKRs. Also, with the exception of Mycobacterium gastri, all spe-
cies carrying clade Ia homologs are human or animal pathogens
(55) (Fig. 5). This pattern is consistent with the observation that
PDIM is one of the pathogenicity determinants of mycobacteria
(3–11). Clade Ib homologs and most members of clade II were
from fast-growing mycobacterial species (Fig. 5), and the available
data suggest that these organisms are devoid of PDIM (55). A
BLASTP analysis showed that these species harbored weaker ho-
mologs of PapA5 that exhibited 40% amino acid sequence identity
to M. tuberculosis PapA5; for the organisms with PDIM, the re-
spective sequence identity values were 80%. However, every
protein shown in Fig. 5 carried the conserved F420-binding resi-
dues shown in Fig. 2 (data not shown). Accordingly, we hypothe-
size that clade Ib and II homologs reduce keto groups or oxidize
hydroxyl groups on lipids or lipid domains of more complex com-
pounds by using F420 as an electron carrier.
FIG 5 Maximum likelihood phylogenetic analysis of F420H2-dependent ph-
thiodiolone ketoreductase (fPKR) homologs in mycobacteria. Homologs with
amino acid sequence identities to Mycobacterium tuberculosis fPKR (the
Rv2915c protein) of50% were analyzed, and the method was performed as
described previously (32). The coenzyme F420-dependent N
5,N10-methylene
tetrahydromethanopterin reductase (Mer) from Methanopyrus kandleri (37)
was used as the outgroup. The names of the slow-growing mycobacterial spe-
cies (52) and the respective Rv2951c protein homologs are shown in red; the
rest are fast growers (52)., the fPKRs of M. tuberculosis H37Rv (the Rv2951c
protein) and M. bovis BCG strain Pasteur 1173P2 (the BCG_2972c protein)
have identical amino acid sequences. The dots near the branches indicate boot-
strap values of 70 (calculated for 100 replicates). The homologs in clade Ia
are 80% identical to the Rv2951c protein at the amino acid sequence level
and belong to slow-growing mycobacterial species that contain PDIM (52, 55)
and carry the gene for an acyltransferase (PapA5) that catalyzes the committed
step of PDIM biosynthesis (56). With the exception of Mycobacterium gastri,
the species harboring clade Ia homologs are human or animal pathogens (55).
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fPKR expands the list of experimentally validated F420-depen-
dent enzymes in M. tuberculosis to six (18, 39, 60), among which
Fgd, fHMAD, and fPKR are Mer homologs (Fig. 2) (18, 19, 39)
and the others are F420H2-dependent quinone reductases (Fqr) or
Ddn family proteins (the Rv3547, Rv1261c, and Rv1558 proteins)
(60). These enzymes represent a part of the full potential, as M.
tuberculosis has been predicted to carry at least 28 F420-dependent
enzymes (20), and one of the identified Ddn homologs (the
Rv3178 protein) has yet to be studied for enzymatic activity (60).
This is an important gap, as all F420-dependent systems of M.
tuberculosis investigated thus far have been linked to TB pathogen-
esis and/or found to be relevant to the development of TB thera-
peutics (26, 39, 60, 61). Fgd is the principal enzyme for the gener-
ation of reduced F420H2 (18, 44, 49), which is likely used by M.
tuberculosis in combating oxidative or nitrosative stress (44, 49,
60). For example, F420H2 allows this pathogen to covert highly
toxic nitrogen dioxide (NO2) to nitric oxide (NO) via chemical
reduction (44); the organism is very sensitive to NO2 and almost
resistant to NO (44, 62). Similarly, a mutant strain of M. tubercu-
losis that is devoid of F420 is hypersensitive to oxidative stress, as it
cannot provide F420H2 for the three F420H2-dependent quinone
reductases discussed above, which protect mycobacteria against
oxidative stress (60). One of these reductases (Ddn, encoded by
the Rv3547 ORF) acts as a nitroreductase to activate a prodrug
called PA-824, a promising anti-TB drug that acts in concert with
F420H2 (45, 60, 63, 64). The hydroxymycolic acid dehydrogenase
(fHMAD), which generates ketomycolic acids (K-MA) from hy-
droxymycolic acids (H-MA), and fPKR studied here exemplify the
critical role of F420 in the functionalization of the formidable cell
wall lipids that protect M. tuberculosis from the host immune at-
tack and from anti-TB drugs (12, 39, 61, 65–70). Also, fHMAD is
one of the targets of PA-824 (39). Some of the mycobacterial F420-
dependent enzymes catalyze decolorization of triphenylmethane
dyes and degradation of aflatoxins (22, 46, 48, 71), and it is likely
that these enzymes catalyze more physiologically relevant cellular
functions in vivo, some of which may have roles in TB pathogen-
esis. The information presented in Fig. 5 brings several potentially
novel F420-dependent lipid-modifying enzymes into focus. Thus,
this report, in addition to defining the electron donor requirement
of an important enzyme of pathogenic mycobacteria, further em-
phasizes a broad influence of F420 in the physiology of the myco-
bacteria in general.
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